Heine A - Search Results

1

Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells.

Grünebach F, Erndt S, Häntschel M, Heine A, Brossart P. Grünebach F, et al. Among authors: heine a. Cancer Immunol Immunother. 2008 Oct;57(10):1483-91. doi: 10.1007/s00262-008-0486-5. Epub 2008 Feb 27. Cancer Immunol Immunother. 2008. PMID: 18301890 Free PMC article.

2

Processing and presentation of HLA class I and II epitopes by dendritic cells after transfection with in vitro-transcribed MUC1 RNA.

Dörfel D, Appel S, Grünebach F, Weck MM, Müller MR, Heine A, Brossart P. Dörfel D, et al. Among authors: heine a. Blood. 2005 Apr 15;105(8):3199-205. doi: 10.1182/blood-2004-09-3556. Epub 2004 Dec 23. Blood. 2005. PMID: 15618468 Free article.

3

Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.

Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P. Heine A, et al. Mol Ther. 2006 Feb;13(2):280-8. doi: 10.1016/j.ymthe.2005.08.019. Epub 2005 Oct 10. Mol Ther. 2006. PMID: 16219490 Free article.

4

Matrilysin (MMP-7) is a novel broadly expressed tumor antigen recognized by antigen-specific T cells.

Yokoyama Y, Grünebach F, Schmidt SM, Heine A, Häntschel M, Stevanovic S, Rammensee HG, Brossart P. Yokoyama Y, et al. Among authors: heine a. Clin Cancer Res. 2008 Sep 1;14(17):5503-11. doi: 10.1158/1078-0432.CCR-07-4041. Clin Cancer Res. 2008. PMID: 18765542

5

RNA vaccines in cancer treatment.

Bringmann A, Held SA, Heine A, Brossart P. Bringmann A, et al. Among authors: heine a. J Biomed Biotechnol. 2010;2010:623687. doi: 10.1155/2010/623687. Epub 2010 Jun 1. J Biomed Biotechnol. 2010. PMID: 20625504 Free PMC article. Review.

6

Immunotherapy in renal cell carcinoma.

Heine A, Holderried TA, Brossart P. Heine A, et al. Immunotherapy. 2009 Jan;1(1):97-107. doi: 10.2217/1750743X.1.1.97. Immunotherapy. 2009. PMID: 20635977 Review.

7

Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.

Rittig SM, Haentschel M, Weimer KJ, Heine A, Muller MR, Brugger W, Horger MS, Maksimovic O, Stenzl A, Hoerr I, Rammensee HG, Holderried TA, Kanz L, Pascolo S, Brossart P. Rittig SM, et al. Among authors: heine a. Mol Ther. 2011 May;19(5):990-9. doi: 10.1038/mt.2010.289. Epub 2010 Dec 28. Mol Ther. 2011. PMID: 21189474 Free PMC article. Clinical Trial.

8

Regulation of dectin-1-mediated dendritic cell activation by peroxisome proliferator-activated receptor-gamma ligand troglitazone.

Kock G, Bringmann A, Held SA, Daecke S, Heine A, Brossart P. Kock G, et al. Among authors: heine a. Blood. 2011 Mar 31;117(13):3569-74. doi: 10.1182/blood-2010-08-302224. Epub 2011 Feb 4. Blood. 2011. PMID: 21296999 Free article.

9

Imatinib mesylate and nilotinib affect MHC-class I presentation by modulating the proteasomal processing of antigenic peptides.

Held SA, Duchardt KM, Tenzer S, Rückrich T, von Schwarzenberg K, Bringmann A, Kurts C, Schild H, Driessen C, Brossart P, Heine A. Held SA, et al. Among authors: heine a. Cancer Immunol Immunother. 2013 Apr;62(4):715-26. doi: 10.1007/s00262-012-1373-7. Epub 2012 Nov 25. Cancer Immunol Immunother. 2013. PMID: 23184338 Free PMC article.

10

Regression of liver metastases after treatment with oxaliplatin/capecitabine and development of a progressive multifocal leukoencephalopathy in a patient with advanced thymoma.

Heine A, Schmiedel A, Menschik T, Held SA, Erdmann C, Brossart P. Heine A, et al. J Clin Oncol. 2013 Apr 20;31(12):e203-5. doi: 10.1200/JCO.2012.43.8150. Epub 2013 Mar 18. J Clin Oncol. 2013. PMID: 23509314 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

346 results

Search Page